Literature DB >> 23624776

Short and long access to cocaine self-administration activates tyrosine phosphatase STEP and attenuates GluN expression but differentially regulates GluA expression in the prefrontal cortex.

Wei-Lun Sun1, Agnieszka Zelek-Molik, Jacqueline F McGinty.   

Abstract

RATIONALE: Dephosphorylation of extracellular signal-regulated kinase (ERK) and cyclic AMP response element binding protein (CREB) in the dorsomedial prefrontal cortex (dmPFC) at the end of short access (ShA) cocaine self-administration is implicated in cocaine seeking. However, what receptors and phosphatases mediate this effect and whether ERK/CREB and related phospho-proteins in the dmPFC react similarly during early withdrawal from long access (LgA) cocaine self-administration are unknown.
OBJECTIVES: The effects of ShA vs. LgA cocaine self-administration on the phosphorylation of protein phosphatase 2A (PP2A) and striatal-enriched protein tyrosine phosphatase (STEP), as well as GluN and GluA receptor subtype expression in the dmPFC during early withdrawal, were compared.
METHODS: Rats self-administered cocaine or received saline during 2- or 6-h daily sessions for 10-11 days. Two hours after the final session, the dmPFC was dissected out and processed for immunoblotting.
RESULTS: Similar to previous findings after ShA cocaine, phospho-ERK and phospho-CREB in the dmPFC were decreased after LgA cocaine. Cocaine elevated phospho-PP2A (deactivation) and decreased phospho-STEP (activation) in both ShA and LgA cocaine rats. GluN1, GluN2B, and phospho-GluN2B Tyr1472 in the dmPFC were decreased after ShA and LgA cocaine. Further, a significant reduction of GluA2, GluA1, and phospho-GluA1 Ser845 was found only in LgA rats.
CONCLUSIONS: Activation of phospho-STEP may underlie ERK and CREB dephosphorylation in the dmPFC as well as internalization and degradation of GluN complexes during early withdrawal from both ShA and LgA cocaine self-administration, whereas differential alteration of AMPA receptor subunits after ShA and LgA cocaine self-administration depends on cocaine intake.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23624776      PMCID: PMC3784626          DOI: 10.1007/s00213-013-3118-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  91 in total

1.  Selective activation induced cleavage of the NR2B subunit by calpain.

Authors:  Kelly L Simpkins; Rodney P Guttmann; Yina Dong; Zhaoming Chen; Set Sokol; Robert W Neumar; David R Lynch
Journal:  J Neurosci       Date:  2003-12-10       Impact factor: 6.167

2.  Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase.

Authors:  T G Banke; D Bowie; H Lee; R L Huganir; A Schousboe; S F Traynelis
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

3.  Histone deacetylase 5 limits cocaine reward through cAMP-induced nuclear import.

Authors:  Makoto Taniguchi; Maria B Carreira; Laura N Smith; Benjamin C Zirlin; Rachael L Neve; Christopher W Cowan
Journal:  Neuron       Date:  2012-01-12       Impact factor: 17.173

4.  Extrasynaptic membrane trafficking regulated by GluR1 serine 845 phosphorylation primes AMPA receptors for long-term potentiation.

Authors:  Michael C Oh; Victor A Derkach; Eric S Guire; Thomas R Soderling
Journal:  J Biol Chem       Date:  2005-11-04       Impact factor: 5.157

5.  Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits.

Authors:  T Ishii; K Moriyoshi; H Sugihara; K Sakurada; H Kadotani; M Yokoi; C Akazawa; R Shigemoto; N Mizuno; M Masu
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

6.  Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5.

Authors:  J A Bibb; J Chen; J R Taylor; P Svenningsson; A Nishi; G L Snyder; Z Yan; Z K Sagawa; C C Ouimet; A C Nairn; E J Nestler; P Greengard
Journal:  Nature       Date:  2001-03-15       Impact factor: 49.962

7.  Glutamatergic plasticity in medial prefrontal cortex and ventral tegmental area following extended-access cocaine self-administration.

Authors:  M Behnam Ghasemzadeh; Preethi Vasudevan; Chad Giles; Anthony Purgianto; Chad Seubert; John R Mantsch
Journal:  Brain Res       Date:  2011-06-23       Impact factor: 3.252

8.  NR2B tyrosine phosphorylation modulates fear learning as well as amygdaloid synaptic plasticity.

Authors:  Takanobu Nakazawa; Shoji Komai; Ayako M Watabe; Yuji Kiyama; Masahiro Fukaya; Fumiko Arima-Yoshida; Reiko Horai; Katsuko Sudo; Kazumi Ebine; Mina Delawary; June Goto; Hisashi Umemori; Tohru Tezuka; Yoichiro Iwakura; Masahiko Watanabe; Tadashi Yamamoto; Toshiya Manabe
Journal:  EMBO J       Date:  2006-05-18       Impact factor: 11.598

9.  Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.

Authors:  J A Bibb; G L Snyder; A Nishi; Z Yan; L Meijer; A A Fienberg; L H Tsai; Y T Kwon; J A Girault; A J Czernik; R L Huganir; H C Hemmings; A C Nairn; P Greengard
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

10.  Protein phosphatase 2A positively and negatively regulates Ras1-mediated photoreceptor development in Drosophila.

Authors:  D A Wassarman; N M Solomon; H C Chang; F D Karim; M Therrien; G M Rubin
Journal:  Genes Dev       Date:  1996-02-01       Impact factor: 11.361

View more
  20 in total

Review 1.  Cocaine self-administration causes signaling deficits in corticostriatal circuitry that are reversed by BDNF in early withdrawal.

Authors:  Jacqueline F McGinty; Agnieska Zelek-Molik; Wei-Lun Sun
Journal:  Brain Res       Date:  2014-09-28       Impact factor: 3.252

2.  Intra-prelimbic cortical inhibition of striatal-enriched tyrosine phosphatase suppresses cocaine seeking in rats.

Authors:  Ben M Siemsen; Paul J Lombroso; Jacqueline F McGinty
Journal:  Addict Biol       Date:  2017-03-28       Impact factor: 4.280

3.  Biphasic effect of abstinence duration following cocaine self-administration on spine morphology and plasticity-related proteins in prelimbic cortical neurons projecting to the nucleus accumbens core.

Authors:  B M Siemsen; G Giannotti; J A McFaddin; M D Scofield; Jacqueline F McGinty
Journal:  Brain Struct Funct       Date:  2018-11-29       Impact factor: 3.270

4.  Role of Src Family Kinases in BDNF-Mediated Suppression of Cocaine-Seeking and Prevention of Cocaine-Induced ERK, GluN2A, and GluN2B Dephosphorylation in the Prelimbic Cortex.

Authors:  Sarah M Barry; Jacqueline F McGinty
Journal:  Neuropsychopharmacology       Date:  2017-06-06       Impact factor: 7.853

5.  Glutamatergic neurotransmission in the prefrontal cortex mediates the suppressive effect of intra-prelimbic cortical infusion of BDNF on cocaine-seeking.

Authors:  Bok Soon Go; Sarah M Barry; Jacqueline F McGinty
Journal:  Eur Neuropsychopharmacol       Date:  2016-10-17       Impact factor: 4.600

6.  PPARγ agonism attenuates cocaine cue reactivity.

Authors:  William R Miller; Robert G Fox; Sonja J Stutz; Scott D Lane; Larry Denner; Kathryn A Cunningham; Kelly T Dineley
Journal:  Addict Biol       Date:  2016-11-11       Impact factor: 4.280

Review 7.  Corticostriatal BDNF and alcohol addiction.

Authors:  Marian L Logrip; Segev Barak; Vincent Warnault; Dorit Ron
Journal:  Brain Res       Date:  2015-03-21       Impact factor: 3.252

8.  Cocaine-induced changes of synaptic transmission in the striatum are modulated by adenosine A2A receptors and involve the tyrosine phosphatase STEP.

Authors:  Valentina Chiodi; Cinzia Mallozzi; Antonella Ferrante; Jiang F Chen; Paul J Lombroso; Anna Maria Michela Di Stasi; Patrizia Popoli; Maria Rosaria Domenici
Journal:  Neuropsychopharmacology       Date:  2013-08-30       Impact factor: 7.853

Review 9.  Molecular Mechanism: ERK Signaling, Drug Addiction, and Behavioral Effects.

Authors:  Wei-Lun Sun; Pamela M Quizon; Jun Zhu
Journal:  Prog Mol Biol Transl Sci       Date:  2015-11-17       Impact factor: 3.622

Review 10.  Epigenetics of Drug Addiction.

Authors:  Andrew F Stewart; Sasha L Fulton; Ian Maze
Journal:  Cold Spring Harb Perspect Med       Date:  2021-07-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.